載入...
Extended-Release Naltrexone To Prevent Relapse Among Opioid Dependent, Criminal Justice System Involved Adults: Rationale and Design of a Randomized Controlled Effectiveness Trial
BACKGROUND: Extended-release naltrexone (XR-NTX, Vivitrol® Alkermes Inc.) is an injectable monthly sustained-release mu opioid receptor antagonist. XR-NTX is a potentially effective intervention for opioid use disorders and as relapse prevention among criminal justice system (CJS) populations. METHO...
Na minha lista:
| 發表在: | Contemp Clin Trials |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4380547/ https://ncbi.nlm.nih.gov/pubmed/25602580 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cct.2015.01.005 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|